RhumbLine Advisers
KALA icon

RhumbLine Advisers’s KALA BIO KALA Stock Holding History

RhumbLine Advisers’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27
Closed -$94K – 3169
2022
Q1 		$94K Hold
27
– – ﹤0.01% 2898
2021
Q4 		$81K Hold
27
– – ﹤0.01% 2958
2021
Q3 		$175K Buy
27
+1
+4% +$8.63K ﹤0.01% 2930
2021
Q2 		$344K Buy
26
+3
+13% +$47.2K ﹤0.01% 2732
2021
Q1 		$387K Buy
23
+1
+5% +$19.5K ﹤0.01% 2602
2020
Q4 		$374K Buy
22
+1
+5% +$18.8K ﹤0.01% 2567
2020
Q3 		$393K Sell
21
-3
-13% -$69K ﹤0.01% 2401
2020
Q2 		$635K Buy
24
+11
+85% +$312K ﹤0.01% 2238
2020
Q1 		$296K Buy
13
+1
+8% +$16K ﹤0.01% 2415
2019
Q4 		$112K Buy
12
+1
+9% +$9.66K ﹤0.01% 2865
2019
Q3 		$109K Hold
11
– – ﹤0.01% 2872
2019
Q2 		$168K Buy
11
+3
+38% +$49.7K ﹤0.01% 2833
2019
Q1 		$161K Buy
8
+2
+33% +$35.5K ﹤0.01% 2795
2018
Q4 		$75K Buy
+6
New +$104K ﹤0.01% 2911
2018
Q3 		– Sell
-4
Closed -$148K – 2927
2018
Q2 		$148K Buy
+4
New +$153K ﹤0.01% 2807

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

RhumbLine Advisers's KALA Position: Q2 2022 in Review

RhumbLine Advisers sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 27 shares — an estimated $94K sold.

RhumbLine Advisers first reported a position in KALA in Q2 2018 and held it in 15 quarters. The position peaked at $635K in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • RhumbLine Advisers reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 27 KALA BIO shares in Q2 2022, an estimated $94K.
  • RhumbLine Advisers first reported a position in KALA BIO in Q2 2018 and held it in 15 quarters.
  • RhumbLine Advisers's KALA BIO position peaked at $635K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.